A recent study demonstrated that hinokitiol treatment induces tumor cell death via sensitization of human lung cancers to TNF-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and suppression of X-linked inhibitor of apoptosis protein (XIAP) 15. Here, XIAP is linked to lung cancer.